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S U M M A R Y
The discovery of viruses in the ﬁnal years of the nineteenth century represented the culmination of two
decades of work on tobacco mosaic disease by three botanical scientists. Eventually their discovery led to
a paradigm shift in scientiﬁc thought, but it took more than 20 years to appreciate its implications
because it was inconsistent with the prevailing dogma of the time—Koch’s postulates. Although these
‘rules’ were actually conceived of as guidelines upon which to establish microbial causality and their
implementation resulted in many new discoveries, they also had the unintended effect of limiting the
interpretation of novel ﬁndings. However, by challenging existing dogma through rigorous scientiﬁc
observation and sheer persistence, the investigators advanced medicine and heralded new areas of
discovery.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The latter part of the nineteenth century witnessed major
developments in medicine with the inception of microbiology as a
distinct science. Although microbes had been identiﬁed in standing
rain water, sea water, and human teeth scrapings by the Dutch
textile merchant and amateur scientist Antonie van Leeuwenhoek
using his handcrafted lenses nearly 200 years earlier, the
signiﬁcance of these ‘‘little animalcules’’ to human health and
disease was unappreciated at the time.1 Over the ensuing two
centuries, through the observations and empiric efforts of
individuals such as Ignaz Semmelweis, working to prevent
puerperal sepsis in Austria; John Snow, mapping the epidemic
curve of cholera in South London and in so doing, becoming the
ﬁrst ‘shoe-leather’ epidemiologist; and Miles Berkeley, solving the
fungal etiology of the socioeconomically devastating Irish potato
blight, the concept that microbial organisms caused human
diseases—the ‘‘germ theory of disease’’—gained adherents.2
2. The inception of dogma
In 1857 Louis Pasteur, an industrial chemist by training,
demonstrated that microorganisms were responsible for the
fermentation of ﬂuids.3 A few years later, he debunked the extant
theory of spontaneous generation, proving instead that microbial
agents were the cause of putrefaction. These events essentially
established microbiology as a distinct science. Shortly thereafter,
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studies that established the bacterial causes of diseases such as
anthrax, cholera, and tuberculosis.
It was in the context of his isolation of the causative agent of
tuberculosis in 1882 that Koch proposed a set of criteria for
assigning a microbial etiology to a speciﬁc disease. These ‘rules’
would rapidly disseminate and become dogma throughout the
scientiﬁc world. ‘‘Koch’s postulates’’, although attributed to the
great microbiologist and probably derived to some degree from
earlier work by the famous German anatomist Jakob Henle, were
actually ﬁrst articulated in published form by his assistant
Friedrich Loefﬂer, who would become a renowned bacteriologist
in his own right. In Loefﬂer’s 1883 paper on the bacterial etiology of
diphtheria,4 he described the criteria for establishing microbial
causality, stated and reﬁned by Koch himself in the context of his
tuberculosis work: the pathogen must be found in every case of the
disease and must account for its clinical and pathological features;
the pathogen cannot be found in other disease states as a non-
pathogen; and after isolation from diseased tissues and repeated
passage in pure culture, the pathogen can induce the same disease
in animal models.5 Some contemporary reviewers added the
additional caveat that the same pathogen must be re-isolated from
the experimental host.
Although Koch himself appears to have realized the limitations
of portions of his postulates as applied to speciﬁc organisms, the
scientiﬁc community rapidly embraced them.4 They provided a
framework for scientists to experimentally ascribe medical
importance to microbes, spurring a period of rapid discovery of
the bacterial etiologies of many of the most important diseases of
the era and leading to the general belief that an identiﬁable
microorganism could be assigned to each infectious disease.
However, the strict devotion to these nascent principles also hadses. Published by Elsevier Ltd. All rights reserved.
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and understanding of novel scientiﬁc ﬁndings.
3. The botanical scientists and ﬁlterable agents
Five years before Koch began his landmark work on tuberculo-
sis in Berlin, Adolf Mayer (Figure 1), a German agricultural chemist,
was appointed as the inaugural Director of the Agricultural
Experiment Station and Professor of Botany at the new Agricultural
School in Wageningen, a small town in the west-central
Netherlands near the German border.6 Beginning in 1879 and
for the next 10 years thereafter, Mayer’s laboratory research was
devoted to a disease of tobacco plants that had plagued local
farmers in the region. In recognition of the heterogeneously
pigmented spots on the diseased leaves, he had named the
afﬂiction ‘‘tobacco mosaic disease’’ (Figure 2).
In an attempt to satisfy Koch’s postulates, which had already
become accepted as necessary requirements to prove a microbial
etiology of a particular disease by the time the Director had
become seriously engaged in mosaic disease research, Mayer
performed the usual microbiologic experiments. Although unable
to identify microbes in diseased plants, he proved that the disease
was transmissible by replicating the disorder upon inoculation of
healthy plants with sap expressed from the leaves of diseased
plants.7 However, unlike bacteria, which were too large to pass
through laboratory ﬁlters, the agent of tobacco disease remained
infectious after ﬁltration. Mayer recognized the novelty of his
observations, but unable to reconcile them with the prevailing
dogma required to prove causality, he hypothesized the etiologic
agent to be a ‘‘soluble, possibly enzyme-like contagium’’.Figure 1. Adolf Mayer (1843–1942). Reprinted from Phytopathological Classics, No.
7, 1942 (reprinted 1968), American Phytopathological Society, St. Paul, MN.He shared his ﬁndings with a younger colleague at the
Agricultural School, Martinus Beijerinck (Figure 3), a chemist with
an interest in botany who, with Mayer, had founded the local
Natural Science Society.6 After reviewing Mayer’s experimental
data and performing additional experiments, Beijerinck was also
unable to demonstrate the presence of microbes, attributing this to
his own lack of bacteriologic expertise.8 Although Mayer would
subsequently rethink his ‘‘soluble contagium’’ position in favor of a
bacterial etiology, he remained aware that his ﬁndings failed to
satisfy Koch’s postulates regarding causality.
In 1892, more than 1300 miles away from Wageningen, a young
botanical sciences student, Dmitri Ivanowsky (Figure 4), presented
his research results on epidemic tobacco mosaic disease to the
Academy of Sciences of St. Petersburg, Russia. Like Mayer, he too
demonstrated the ‘ﬁlterable’ nature of the transmissible disease
and appropriately concluded that the ﬁltrate was infectious.9 But
as with Mayer, he too interpreted his ﬁndings in the context of the
scientiﬁcally accepted supremacy of Koch’s postulates, proposing
that his ﬁndings represented either laboratory error due to
defective ﬁlters or were due to the presence of other ﬁlterable
materials such as bacterial toxins in the diseased sap.
By 1895 Beijerinck had returned to academia after leaving the
Agricultural School for a 10-year stint in industrial microbiology in
Delft, the South Holland birthplace of van Leeuwenhoek, one of the
founding fathers of microbiology.6 During his ﬁrst years at the
Technical University of Delft, Beijerinck resumed the research on
tobacco mosaic disease that he had started while working with
Mayer. Even then, he had appreciated that the afﬂiction was
microbial in nature, although he felt that the actual agents had yet to
be discovered.8 Beijerinck’s investigations at Delft proved fruitful;
he not only conﬁrmed the infectivity of the contagium vivum
ﬂuidum—soluble living germ—despite ﬁltration, but he importantly
demonstrated that unlike bacteria, the culprit of tobacco diseaseFigure 2. Tobacco leaves infected with tobacco mosaic virus. Reprinted from
Phytopathological Classics, No. 7, 1942 (reprinted 1968), American
Phytopathological Society, St. Paul, MN.
Figure 3. Martinus Beijerinck (1851–1931). Reprinted from Phytopathological
Classics, No. 7, 1942 (reprinted 1968), American Phytopathological Society, St. Paul,
MN.
Figure 4. Dmitri Ivanowsky (1864–1924). Reprinted from Phytopathological
Classics, No. 7, 1942 (reprinted 1968), American Phytopathological Society,
St. Paul, MN.
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presence of living, dividing host cells in order to replicate.8
Through his investigations and building upon the works of
Mayer and Ivanowsky, Beijerinck deﬁnitively established that a
member of a new class of infective agents, one that would come to
be known as ‘viruses’, caused tobacco mosaic disease. But largely
because of extant dogma—Koch’s postulates—it took nearly two
decades, beginning with Mayer’s work, for the scientiﬁc world—
and the investigators themselves—to accept this novel truth. Once
established, their discovery unleashed a torrent of scientiﬁc
investigation that, as with Pasteur and Koch two decades earlier,
again revolutionized medicine.
By the end of the ﬁrst quarter of the twentieth century,
essentially the same 20-year timeframe that it took to establish the
existence of viruses and their involvement in disease, more than
65 diseases of animals and humans had been attributed to these
ﬁlterable agents.10 Furthermore, the ﬂedgling ﬁeld of virology,
launched by the work of the three botanical scientists, laid the
foundations that galvanized the modern molecular era and also
ushered in the ‘golden age of vaccinology’, leading directly to the
prevention of polio, measles, and other scourges of nature.11
4. Challenging dogma as a route to advance science and
medicine
Mayer, Ivanowsky, and Beijerinck were neither the ﬁrst nor will
they be the last in any ﬁeld to challenge existing dogma. Examples
of this abound in the histories of science and medicine. The notion
that germs causing lethal puerperal (‘childbed’) fever were
transmitted to hospitalized, parturient women through thecontaminated hands of obstetricians was considered heresy by
the medical establishment when proposed by Semmelweis in 1847
Vienna.2 His thesis failed to gain acceptance despite the
demonstration that hand washing by physicians and medical
students between patient contacts signiﬁcantly reduced the
mortality from the disease. Two decades later Lister introduced
similar concepts of disinfection, sterility, and antisepsis into
surgical practice in Glasgow.12 The medical community rapidly
embraced these practices, in large part because the intellectual
environment had changed during the 20-year interval between the
work of Semmelweis and Lister. Pasteur had proven the germ
theory of disease, thus moving the ﬁeld forward in a radical way
and establishing a new paradigm—a framework upon which to
interpret such novel discoveries.
As scientiﬁc tools and technology evolved and knowledge
expanded throughout the twentieth century, Koch’s postulates
were revisited and revised. Their ﬁrst major reassessment was
necessitated by the discovery of viruses and its scientiﬁc aftermath:
‘‘At the time when they were formulated Koch’s postulates
were essential for the progress of knowledge in infectious
diseases; but progress having left behind old rules requires new
ones which some day without doubt will also be declared
obsolete. Thus, in regard to certain diseases, particularly those
caused by viruses, the blind adherence to Koch’s postulates may
act as hindrance instead of an aid.’’13
Koch’s postulates—originally established as guidelines for
establishing microbial causality—have since undergone reevalua-
tions multiple times in response to novel paradigms that were
precipitated by new technologies and new knowledge. Most
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genotype-based microbial discovery.14 Common to all such
‘episodes’ of reevaluation is a shift in scientiﬁc thinking that
moves the ﬁeld forward.
Kuhn, in his landmark treatise on the nature of scientiﬁc progress
and discovery, characterized this process as comprising intervals
of ‘‘normal science’’—incremental advances based on past
achievements—punctuated by periods of revolutionary changes in
scientiﬁc thought.15 These ‘game-changing’ episodes of discovery
represent revolutions that challenge dogma and inevitably cause
upheavals within the scientiﬁc community. But these episodes
eventually lead to new paradigms that change thinking and
galvanize further, novel discoveries and in doing so, advance the
ﬁeld. Although Kuhn’s thesis was based on examples from the
physical sciences, it clearly resonates in the biological arenas as well.
The story of the discovery of viruses vividly illustrates the
kinetics of paradigm shifts in scientiﬁc thinking, and how these
changes lead to new discoveries and potentially downstream shifts
that may amplify the discovery process further. Novel or
unexpected ﬁndings, whether originating from the clinic or the
laboratory bench, should rightly force physicians and scientists to
question their experimental and intellectual processes and to
reevaluate their approach. However, careful, reproducible, clinical
or experimental observations that cannot be explained by existing
paradigms or that are not consistent with existing dogma should
not be disregarded. Instead, as with the experimental ﬁndings of
Mayer, Ivanowsky, and Beijerinck, such discoveries may only be
reconciled through the development of novel paradigms.
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